 Pear Therapeutics, Inc. NASDAQ:PEAR Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Meara Murphy - Senior Director of Corporate Communications Ronan OBrien - General Counsel and Chief Compliance Officer Corey McCann - President and Chief Executive Officer Chris Guiffre - Chief Financial Officer and Chief Operating Officer Yuri Maricich - Chief Medical Officer Julia Strandberg - Chief Commercial Officer Conference Call Participants Michael Cherny - Bank of America Charles Rhyee - Cowen Neena Bitritto-Garg - Citi Eric Percher - Nephron Research Keay Nakae - Chardan Judah Frommer - Credit Suisse Marie Thibault - BTIG Operator Good afternoon, everyone. Welcome to the Pear Therapeutics First Quarter 2022 Earnings Conference Call. 